IBRX Operating Cash Flow (Statement)
Immunitybio Inc · Operating Cash Flow (Statement)
IBRX Operating Cash Flow (Statement)
Latest reported-$66.49Mperiod ending
IBRX Quarterly Cash from Operations (-$91.00K → -$66.49M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
IBRX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -66,494,000 | |
| -75,359,000 | |
| -70,378,000 | |
| -68,907,000 | |
| -79,746,000 | |
| -85,905,000 | |
| -85,144,000 | |
| -98,763,000 | |
| -100,347,000 | |
| -106,982,000 | |
| -115,271,000 | |
| -87,403,000 | |
| -79,773,000 | |
| -84,310,000 | |
| -90,727,000 | |
| -80,600,000 | |
| -91,252,000 | |
| -74,930,000 | |
| -71,639,000 | |
| -72,716,000 | |
| -69,595,000 | |
| -60,469,000 | |
| -57,604,000 | |
| -36,991,000 | |
| -46,022,000 | |
| -31,107,000 | |
| -14,885,000 | |
| -16,572,000 | |
| -16,827,000 | |
| -13,078,000 | |
| -14,033,000 | |
| -17,571,000 | |
| -16,266,000 | |
| -15,511,000 | |
| -13,640,000 | |
| -10,133,000 | |
| -14,950,000 | |
| -10,057,000 | |
| -10,753,000 | |
| -10,683,000 | |
| -8,301,000 | |
| -8,856,000 | |
| -11,085,000 | |
| -4,178,000 | |
| -2,721,000 | |
| -7,321,000 | |
| -2,556,000 | |
| -705,000 | |
| -2,002,000 | |
| -91,000 |